Low-dose and standard-dose ticagrelor compared with clopidogrel in patients with acute coronary syndromes: A cohort study from china

PURPOSE: Previous trials have demonstrated that ticagrelor was superior to clopidogrel in acute coronary syndrome (ACS) patients. However, several recent studies showed that ticagrelor was associated with a significantly higher risk of bleeding compared with clopidogrel, especially in East Asian pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Wenxing, Zhang, Yunnan, Lin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360550/
https://www.ncbi.nlm.nih.gov/pubmed/35958420
http://dx.doi.org/10.3389/fcvm.2022.937261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360550/
https://www.ncbi.nlm.nih.gov/pubmed/35958420
http://dx.doi.org/10.3389/fcvm.2022.937261

Ejemplares similares